Produits pharmaceutiques : Principaux
Sociétés Américaines entreprises opérant dans un secteur d'activité: produits pharmaceutiques : principaux
La liste ci-dessous contient les Sociétés Américaines qui opèrent dans le même secteur d'activité, produits pharmaceutiques : principaux. Cette liste permet de suivre leurs performances, leur compte de résultat, etc. Classée en fonction de n'importe quelle métrique nécessaire, elle peut indiquer les actions les plus chères du secteur, comme Eli Lilly and Company, ou celles qui présentent la meilleure dynamique de prix, comme Perrigo Company plc, aidant ainsi à concevoir des stratégies de tout type.
Symbole | Capitalisation boursière | Prix | Variation % | Volume | Volume Rel | P/E | BPA dil TTM | Croissance dil du BPA YoY TTM | Rendement du Dividende % TTM | Secteur | Note des analystes |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 872,91 B USD | 920,63 USD | +1,71% | 4,07 M | 1,18 | 80,13 | 11,49 USD | +102,11% | 0,59% | Technologie de la santé | Buy |
 NVONovo Nordisk A/SDR | 397,95 B USD | 90,65 USD | +1,60% | 5,96 M | 0,65 | 27,62 | 3,28 USD | +21,51% | 1,13% | Technologie de la santé | Buy |
 JNJJohnson & Johnson | 397,3 B USD | 165,02 USD | +0,79% | 12,04 M | 1,24 | 28,46 | 5,80 USD | +3,95% | 3,01% | Technologie de la santé | Buy |
 ABBVAbbVie Inc. | 369,01 B USD | 209,03 USD | +1,96% | 13,14 M | 2,41 | 87,40 | 2,39 USD | −12,09% | 3,01% | Technologie de la santé | Buy |
 AZNAstraZeneca PLCDR | 233,34 B USD | 76,21 USD | +0,74% | 12,81 M | 2,13 | 33,82 | 2,25 USD | +18,08% | 1,99% | Technologie de la santé | Strong Buy |
 MRKMerck & Company, Inc. | 233,03 B USD | 92,25 USD | +1,84% | 15,48 M | 0,85 | 13,70 | 6,73 USD | +4 993,72% | 3,38% | Technologie de la santé | Buy |
 NVSNovartis AGDR | 214,13 B USD | 109,05 USD | +0,12% | 2,33 M | 1,04 | 18,57 | 5,87 USD | −17,77% | 2,93% | Technologie de la santé | Neutre |
 PFEPfizer, Inc. | 149,79 B USD | 26,43 USD | +1,26% | 51,53 M | 1,36 | 18,77 | 1,41 USD | +291,71% | 6,39% | Technologie de la santé | Buy |
 SNYSanofiDR | 135,85 B USD | 54,47 USD | +0,61% | 1,6 M | 0,81 | 22,75 | 2,39 USD | +3,07% | 2,71% | Technologie de la santé | Buy |
 VRTXVertex Pharmaceuticals Incorporated | 123,21 B USD | 479,79 USD | +1,11% | 2,47 M | 1,97 | — | −2,20 USD | −115,85% | 0,00% | Technologie de la santé | Buy |
 BMYBristol-Myers Squibb Company | 120,99 B USD | 59,62 USD | +1,39% | 20,22 M | 1,85 | — | −4,43 USD | −214,79% | 4,06% | Technologie de la santé | Neutre |
 REGNRegeneron Pharmaceuticals, Inc. | 76,39 B USD | 698,74 USD | −0,57% | 1,03 M | 1,41 | 18,25 | 38,29 USD | +10,17% | 0,13% | Technologie de la santé | Buy |
 GSKGSK plcDR | 75,2 B USD | 37,59 USD | +0,78% | 6,05 M | 1,06 | 23,76 | 1,58 USD | −47,11% | 4,06% | Technologie de la santé | Neutre |
 ZTSZoetis Inc. | 74,89 B USD | 167,24 USD | +1,37% | 3,33 M | 0,65 | 30,60 | 5,47 USD | +7,80% | 1,07% | Technologie de la santé | Buy |
 TAKTakeda Pharmaceutical Company LimitedDR | 45,6 B USD | 14,41 USD | +0,49% | 899,73 K | 0,67 | 33,89 | 0,43 USD | +6,33% | 3,51% | Technologie de la santé | Buy |
 ALNYAlnylam Pharmaceuticals, Inc. | 31,94 B USD | 246,75 USD | +4,07% | 1,18 M | 1,40 | — | −2,17 USD | +39,03% | 0,00% | Technologie de la santé | Buy |
 ONCBeiGene, Ltd.DR | 31,02 B USD | 271,80 USD | −2,36% | 964,68 K | 1,53 | — | −6,13 USD | +27,88% | 0,00% | Technologie de la santé | Strong Buy |
 BIIBBiogen Inc. | 20,57 B USD | 140,50 USD | +0,44% | 2,32 M | 1,42 | 12,57 | 11,18 USD | +40,10% | 0,00% | Technologie de la santé | Buy |
 RPRXRoyalty Pharma plc | 19,39 B USD | 33,64 USD | +0,81% | 4,46 M | 0,81 | 17,54 | 1,92 USD | −24,37% | 2,53% | Technologie de la santé | Strong Buy |
 INSMInsmed Incorporated | 14,76 B USD | 81,55 USD | +3,16% | 1,65 M | 0,79 | — | −5,59 USD | −4,45% | 0,00% | Technologie de la santé | Strong Buy |
 UTHRUnited Therapeutics Corporation | 14,37 B USD | 320,05 USD | −1,10% | 657,49 K | 0,98 | 13,01 | 24,60 USD | +24,00% | 0,00% | Technologie de la santé | Buy |
 INCYIncyte Corporation | 14,22 B USD | 73,50 USD | +0,44% | 1,49 M | 0,88 | 271,02 | 0,27 USD | −89,75% | 0,00% | Technologie de la santé | Buy |
 GMABGenmab A/SDR | 14,21 B USD | 22,68 USD | −0,22% | 1,03 M | 0,74 | 12,95 | 1,75 USD | +82,11% | 0,00% | Technologie de la santé | Buy |
 ITCIIntra-Cellular Therapies Inc. | 13,63 B USD | 128,20 USD | −0,04% | 1,49 M | 0,85 | — | −0,72 USD | +50,50% | 0,00% | Technologie de la santé | Neutre |
 NBIXNeurocrine Biosciences, Inc. | 11,84 B USD | 118,72 USD | +1,03% | 1,38 M | 1,06 | 36,07 | 3,29 USD | +35,43% | 0,00% | Technologie de la santé | Buy |
 VTRSViatris Inc. | 11,02 B USD | 9,23 USD | −3,15% | 29,32 M | 2,32 | — | −0,53 USD | −1 358,49% | 5,20% | Technologie de la santé | Neutre |
 EXELExelixis, Inc. | 10,83 B USD | 38,69 USD | +2,76% | 3,72 M | 1,36 | 21,83 | 1,77 USD | +173,87% | 0,00% | Technologie de la santé | Buy |
 RDYDr. Reddy's Laboratories LtdDR | 10,65 B USD | 12,78 USD | −1,31% | 2,51 M | 1,20 | 16,62 | 0,77 USD | +1,40% | 0,63% | Technologie de la santé | Neutre |
 SRPTSarepta Therapeutics, Inc. | 10,2 B USD | 106,75 USD | +3,58% | 1,28 M | 1,36 | 44,79 | 2,38 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ASNDAscendis Pharma A/SDR | 9,37 B USD | 156,58 USD | +2,25% | 429,43 K | 0,70 | — | −7,13 USD | +22,96% | 0,00% | Technologie de la santé | Strong Buy |
 RGENRepligen Corporation | 8,92 B USD | 159,26 USD | +1,74% | 453,32 K | 0,57 | — | −0,46 USD | −173,70% | 0,00% | Technologie de la santé | Buy |
 JAZZJazz Pharmaceuticals plc | 8,72 B USD | 143,53 USD | +0,18% | 1,19 M | 1,12 | 16,41 | 8,75 USD | +51,57% | 0,00% | Technologie de la santé | Strong Buy |
 ROIVRoivant Sciences Ltd. | 7,66 B USD | 10,74 USD | +3,47% | 5,96 M | 1,46 | — | −0,14 USD | −102,78% | 0,00% | Technologie de la santé | Strong Buy |
 MDGLMadrigal Pharmaceuticals, Inc. | 7,54 B USD | 341,27 USD | +1,65% | 330,38 K | 0,79 | — | −22,11 USD | −10,89% | 0,00% | Technologie de la santé | Strong Buy |
 GRFSGrifols, S.A.DR | 6,74 B USD | 8,44 USD | +1,93% | 1,52 M | 1,34 | — | — | — | 0,00% | Technologie de la santé | Neutre |
 LEGNLegend Biotech CorporationDR | 6,42 B USD | 35,01 USD | −4,66% | 1,98 M | 1,67 | — | −1,91 USD | +35,99% | 0,00% | Technologie de la santé | Strong Buy |
 CORTCorcept Therapeutics Incorporated | 6,39 B USD | 60,58 USD | +1,22% | 1,36 M | 1,10 | 49,13 | 1,23 USD | +30,07% | 0,00% | Technologie de la santé | Strong Buy |
 VRNAVerona Pharma plcDR | 5,89 B USD | 69,63 USD | +3,74% | 1,13 M | 0,65 | — | −2,16 USD | −213,94% | 0,00% | Technologie de la santé | Strong Buy |
 ALKSAlkermes plc | 5,58 B USD | 34,33 USD | +0,85% | 1,79 M | 0,95 | 15,75 | 2,18 USD | +5,35% | 0,00% | Technologie de la santé | Buy |
 CYTKCytokinetics, Incorporated | 5,45 B USD | 46,00 USD | −3,06% | 2,02 M | 0,99 | — | −5,28 USD | +3,20% | 0,00% | Technologie de la santé | Strong Buy |
 IONSIonis Pharmaceuticals, Inc. | 5,28 B USD | 33,19 USD | +5,87% | 2,01 M | 1,04 | — | −3,04 USD | −18,79% | 0,00% | Technologie de la santé | Buy |
 TGTXTG Therapeutics, Inc. | 4,68 B USD | 30,09 USD | +5,47% | 2,42 M | 1,47 | — | −0,11 USD | +60,71% | 0,00% | Technologie de la santé | Buy |
 PTCTPTC Therapeutics, Inc. | 4,36 B USD | 55,26 USD | +9,27% | 1,92 M | 3,07 | — | −4,73 USD | +43,51% | 0,00% | Technologie de la santé | Buy |
 PBHPrestige Consumer Healthcare Inc. | 4,2 B USD | 84,75 USD | +1,22% | 445,44 K | 1,51 | 19,86 | 4,27 USD | — | 0,00% | Technologie de la santé | Buy |
 RAREUltragenyx Pharmaceutical Inc. | 3,97 B USD | 42,92 USD | +2,26% | 910,49 K | 1,19 | — | −6,34 USD | +23,93% | 0,00% | Technologie de la santé | Strong Buy |
 PRGOPerrigo Company plc | 3,96 B USD | 29,00 USD | +20,18% | 7,58 M | 4,59 | — | −1,19 USD | −1 630,91% | 3,81% | Technologie de la santé | Buy |
 OGNOrganon & Co. | 3,84 B USD | 14,91 USD | −0,86% | 4,6 M | 1,24 | 4,47 | 3,33 USD | −16,47% | 7,51% | Technologie de la santé | Neutre |
 BHVNBiohaven Ltd. | 3,76 B USD | 37,18 USD | +1,75% | 766,13 K | 1,15 | — | −9,35 USD | −37,39% | 0,00% | Technologie de la santé | Strong Buy |
 AKROAkero Therapeutics, Inc. | 3,69 B USD | 49,12 USD | +2,87% | 648,28 K | 0,79 | — | −3,75 USD | −31,37% | 0,00% | Technologie de la santé | Strong Buy |
 CRNXCrinetics Pharmaceuticals, Inc. | 3,33 B USD | 35,78 USD | +7,74% | 2,04 M | 2,16 | — | −3,70 USD | −0,12% | 0,00% | Technologie de la santé | Strong Buy |
 ACADACADIA Pharmaceuticals Inc. | 3,27 B USD | 19,60 USD | +1,34% | 1,53 M | 0,76 | 14,41 | 1,36 USD | — | 0,00% | Technologie de la santé | Buy |
 VKTXViking Therapeutics, Inc. | 3,24 B USD | 28,87 USD | +0,70% | 3,13 M | 0,51 | — | −1,01 USD | −10,27% | 0,00% | Technologie de la santé | Strong Buy |
 APLSApellis Pharmaceuticals, Inc. | 3,13 B USD | 25,15 USD | −3,27% | 2,96 M | 1,77 | — | −1,60 USD | +64,32% | 0,00% | Technologie de la santé | Buy |
 FOLDAmicus Therapeutics, Inc. | 2,92 B USD | 9,49 USD | +3,26% | 3,04 M | 1,14 | — | −0,18 USD | +64,39% | 0,00% | Technologie de la santé | Buy |
 HCMHUTCHMED (China) LimitedDR | 2,88 B USD | 16,46 USD | −1,02% | 57,41 K | 0,58 | — | −0,25 USD | −16,10% | 0,00% | Technologie de la santé | Strong Buy |
 XENEXenon Pharmaceuticals Inc. | 2,83 B USD | 37,02 USD | −3,37% | 1,34 M | 3,10 | — | −3,01 USD | −10,19% | 0,00% | Technologie de la santé | Strong Buy |
 CPRXCatalyst Pharmaceuticals, Inc. | 2,78 B USD | 22,89 USD | +5,68% | 1,48 M | 1,28 | 17,49 | 1,31 USD | +114,82% | 0,00% | Technologie de la santé | Strong Buy |
 AMRXAmneal Pharmaceuticals, Inc. | 2,69 B USD | 8,67 USD | +3,46% | 2,9 M | 1,85 | — | −0,38 USD | −21,58% | 0,00% | Technologie de la santé | Strong Buy |
 MLTXMoonLake Immunotherapeutics | 2,68 B USD | 41,76 USD | −0,02% | 302,84 K | 0,86 | — | −1,89 USD | −147,80% | 0,00% | Technologie de la santé | Strong Buy |
| MMTSRMetsera, Inc. | 2,61 B USD | 24,78 USD | −0,92% | 632,3 K | 1,16 | — | — | — | 0,00% | Technologie de la santé | Strong Buy |
 VCELVericel Corporation | 2,56 B USD | 51,29 USD | +3,37% | 607,06 K | 1,54 | 277,84 | 0,18 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 IBRXImmunityBio, Inc. | 2,4 B USD | 3,29 USD | +15,03% | 13,13 M | 1,92 | — | −0,89 USD | +15,29% | 0,00% | Technologie de la santé | Buy |
 MIRMMirum Pharmaceuticals, Inc. | 2,33 B USD | 47,57 USD | +1,27% | 513,27 K | 0,83 | — | −1,85 USD | +53,98% | 0,00% | Technologie de la santé | Strong Buy |
 LGNDLigand Pharmaceuticals Incorporated | 2,31 B USD | 122,23 USD | +5,67% | 149,28 K | 1,25 | — | −0,15 USD | −105,31% | 0,00% | Technologie de la santé | Strong Buy |
 NAMSNewAmsterdam Pharma Company N.V. | 2,31 B USD | 21,00 USD | +0,43% | 1,15 M | 1,52 | — | −2,60 USD | −1 203,87% | 0,00% | Technologie de la santé | Strong Buy |
 SLNOSoleno Therapeutics, Inc. | 2,1 B USD | 48,82 USD | +8,51% | 745,65 K | 1,74 | — | −4,26 USD | −43,20% | 0,00% | Technologie de la santé | Strong Buy |
 CNTACentessa Pharmaceuticals plcDR | 2,05 B USD | 15,55 USD | +3,25% | 1,26 M | 1,27 | — | −1,53 USD | +7,72% | 0,00% | Technologie de la santé | Strong Buy |
 AGIOAgios Pharmaceuticals, Inc. | 2,04 B USD | 35,54 USD | +3,49% | 680,87 K | 0,89 | 3,12 | 11,40 USD | — | 0,00% | Technologie de la santé | Buy |
 HRMYHarmony Biosciences Holdings, Inc. | 1,94 B USD | 33,85 USD | +3,36% | 1,03 M | 1,20 | 13,49 | 2,51 USD | +17,72% | 0,00% | Technologie de la santé | Strong Buy |
 TVTXTravere Therapeutics, Inc. | 1,9 B USD | 21,40 USD | +3,68% | 2 M | 1,13 | — | −4,10 USD | +10,01% | 0,00% | Technologie de la santé | Strong Buy |
 IDYAIDEAYA Biosciences, Inc. | 1,8 B USD | 20,57 USD | +1,63% | 1,14 M | 1,17 | — | −3,30 USD | −67,97% | 0,00% | Technologie de la santé | Strong Buy |
 SUPNSupernus Pharmaceuticals, Inc. | 1,79 B USD | 32,06 USD | +0,94% | 675,7 K | 0,79 | 24,32 | 1,32 USD | — | 0,00% | Technologie de la santé | Buy |
 BLTEBelite Bio, IncDR | 1,77 B USD | 57,20 USD | −1,82% | 70,58 K | 2,44 | — | −1,11 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 TARSTarsus Pharmaceuticals, Inc. | 1,71 B USD | 44,48 USD | +2,14% | 845,64 K | 1,18 | — | −3,10 USD | +33,12% | 0,00% | Technologie de la santé | Strong Buy |
 AAPGAscentage Pharma Group International - American Depository SharesDR | 1,67 B USD | 19,03 USD | −3,89% | 43,92 K | 0,47 | — | −0,70 USD | +63,05% | 0,00% | Technologie de la santé | — |
 ARQTArcutis Biotherapeutics, Inc. | 1,62 B USD | 13,69 USD | +6,95% | 2,61 M | 1,08 | — | −1,16 USD | +70,23% | 0,00% | Technologie de la santé | Strong Buy |
 MNKDMannKind Corporation | 1,62 B USD | 5,34 USD | +2,10% | 2,99 M | 1,40 | 58,36 | 0,09 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 EVOEvotec SEDR | 1,51 B USD | 4,22 USD | −3,87% | 137,23 K | 3,14 | — | −0,52 USD | +5,42% | 0,00% | Technologie de la santé | Buy |
 KNSAKiniksa Pharmaceuticals, Ltd. | 1,47 B USD | 20,28 USD | +3,31% | 733,83 K | 1,46 | — | −0,61 USD | −430,93% | 0,00% | Technologie de la santé | Strong Buy |
 AMPHAmphastar Pharmaceuticals, Inc. | 1,37 B USD | 28,43 USD | −9,72% | 1,79 M | 3,10 | 9,28 | 3,06 USD | +18,36% | 0,00% | Technologie de la santé | Buy |
 ETNB89bio, Inc. | 1,35 B USD | 9,23 USD | −0,97% | 2,49 M | 1,75 | — | −3,43 USD | −70,45% | 0,00% | Technologie de la santé | Strong Buy |
 LQDALiquidia Corporation | 1,31 B USD | 15,49 USD | +0,85% | 1,08 M | 1,48 | — | −1,62 USD | −82,56% | 0,00% | Technologie de la santé | Strong Buy |
 ARDXArdelyx, Inc. | 1,28 B USD | 5,36 USD | +2,68% | 3,65 M | 0,87 | — | −0,17 USD | +44,62% | 0,00% | Technologie de la santé | Strong Buy |
 VRDNViridian Therapeutics, Inc. | 1,23 B USD | 15,53 USD | +1,57% | 1,12 M | 1,27 | — | −3,96 USD | +25,57% | 0,00% | Technologie de la santé | Strong Buy |
 NRIXNurix Therapeutics, Inc. | 1,17 B USD | 15,45 USD | +3,00% | 1,11 M | 1,56 | — | −2,89 USD | −9,10% | 0,00% | Technologie de la santé | Strong Buy |
 INDVIndivior PLC | 1,15 B USD | 9,24 USD | +4,05% | 2,96 M | 1,51 | — | −0,36 USD | −4 084,54% | 0,00% | Technologie de la santé | Strong Buy |
 INVAInnoviva, Inc. | 1,12 B USD | 17,92 USD | +2,11% | 648,54 K | 1,26 | 85,66 | 0,21 USD | −90,42% | 0,00% | Technologie de la santé | — |
 OCULOcular Therapeutix, Inc. | 1,12 B USD | 7,14 USD | +2,88% | 1,22 M | 1,34 | — | −1,32 USD | −18,71% | 0,00% | Technologie de la santé | Strong Buy |
 PCRXPacira BioSciences, Inc. | 1,11 B USD | 24,05 USD | −5,24% | 1,67 M | 2,21 | — | −2,20 USD | −383,89% | 0,00% | Technologie de la santé | Neutre |
 SPRYARS Pharmaceuticals, Inc. | 1,02 B USD | 10,48 USD | +2,75% | 905,76 K | 0,74 | — | −0,51 USD | +79,10% | 0,00% | Technologie de la santé | Strong Buy |
 HROWHarrow, Inc. | 1 B USD | 28,08 USD | +1,89% | 200,5 K | 0,63 | — | −0,94 USD | −108,90% | 0,00% | Technologie de la santé | Strong Buy |
 GYREGyre Therapeutics, Inc. | 995,54 M USD | 11,60 USD | +2,75% | 38,44 K | 0,69 | — | — | — | 0,00% | Technologie de la santé | — |
 OCSOculis Holding AG | 939,84 M USD | 19,58 USD | −0,51% | 38,42 K | 0,72 | — | −2,01 USD | — | 0,00% | Technologie de la santé | Strong Buy |
 ZYMEZymeworks Inc. | 930,61 M USD | 13,40 USD | +0,45% | 807,97 K | 2,31 | — | −1,51 USD | −148,37% | 0,00% | Technologie de la santé | Buy |
 EOLSEvolus, Inc. Common Stock | 923,86 M USD | 14,59 USD | +3,77% | 491,92 K | 0,69 | — | −0,91 USD | +17,74% | 0,00% | Technologie de la santé | Strong Buy |
 BGMBGM Group Ltd. | 921,67 M USD | 9,48 USD | −2,72% | 2,21 K | 0,30 | — | −0,25 USD | −12,78% | 0,00% | Technologie de la santé | — |
 PAHCPhibro Animal Health Corporation | 921,05 M USD | 22,74 USD | +2,85% | 400,06 K | 1,30 | 47,77 | 0,48 USD | +30,27% | 2,11% | Technologie de la santé | Sell |
 DAWNDay One Biopharmaceuticals, Inc. | 918,27 M USD | 9,06 USD | −3,97% | 2,35 M | 2,11 | — | −1,04 USD | +56,05% | 0,00% | Technologie de la santé | Strong Buy |
 COLLCollegium Pharmaceutical, Inc. | 914,65 M USD | 29,05 USD | +2,22% | 697,75 K | 2,21 | 15,72 | 1,85 USD | +55,98% | 0,00% | Technologie de la santé | Strong Buy |
 PHVSPharvaris N.V. | 858,72 M USD | 15,90 USD | +2,19% | 44,82 K | 1,12 | — | −2,68 USD | +16,70% | 0,00% | Technologie de la santé | Strong Buy |